Company intelligence / Profile preview

BeauCare Clinics Investment

Beijing, China

Ownership: Private
Development stage: Other

Overview

BeauCare Clinics operates over 60 medical aesthetics hospitals and clinics across 15 cities in China, making it the largest doctor entrepreneurship platform and medical aesthetics group with the most chain members in China. The company has expanded into supply chain business with a group purchasing alliance of more than 400 alliance members across 30+ cities as of Q1 2025.

Therapeutic areas: Women's HealthOtherOphthalmologyDermatology
Industry: Non-Academic Healthcare

Partnerships

Apyx Medical Corporation (Renuvion distribution agreement in China, 2025)

Beyond the preview

Go deeper on BeauCare Clinics Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BeauCare Clinics Investment.

Explore the full profile